Epidemiological and Diagnostic study of Toxoplasma gondii in Cats and Humans Using Microscopic and Serological Methods in Shahat City
DOI:
https://doi.org/10.58987/x8ws0t34Keywords:
Toxoplasmosis, Toxoplasma gondii, IgM, IgG, Shahat CityAbstract
Toxoplasma gondii, the causative agent of toxoplasmosis, represents a significant public health concern due to its wide distribution and zoonotic potential between cats and humans. This study aimed to investigate the occurrence of T. gondii in cat feces and human blood within the same study area (Shahat City). Cat fecal samples examined using Sheather's Sugar Flotation Technique, and human blood samples analyzed using the enzyme-linked immunosorbent assay (ELISA) technique. The overall prevalence of T. gondii infection in Shahat City was 65%. The infection rate among female cats (84.6%) was significantly higher than that of male cats (15.3%). Regarding lifestyle, free-roaming cats showed the highest prevalence (41.0%), followed by semi-confined cats (38.4%), and while indoor confined cats had the lowest rate (20.5%). By age, cats older than two years up to more than four years exhibited the highest infection rate (46.1%), whereas the lowest rate was in the 12–24 month age group (20.5%). Seasonally, prevalence was highest in summer (80.0%), followed by spring (69.3%), autumn (54.6%), and lowest in winter (23.0%). Furthermore, serological analysis of human blood samples demonstrated that 32.2% of individuals were positive for IgM, while 78.9% were positive for IgG. These findings highlight the urgent need for strategies to minimize and control the prevalence of toxoplasmosis.
References
[1] R. Mahdi, L. Omar, “Urbanization and zoonotic parasite dynamics in North Africa,” Journal of Global Health Research, Vol. 9(1), 44-59, 2025.
[2] Y. Zhang, J. Kim, “Toxoplasma gondii: Advances in understanding its zoonotic transmission and public health implications,” Parasites and Vectors, Vol. 17(3), 225, 2024.
[3] F.S. Nazarova, R.N. Kuvondilova, “Toxoplasma gondii,” British Journal of Global Ecology and Sustainable Development, Vol. 26(1), 56-59, 2024.
[4] S. Rahman, P. Torres, “Maternal-fetal transmission of toxoplasmosis: Global perspectives and regional disparities,” BMC Infectious Diseases, Vol. 25(2), 34-52, 2025.
[5] A. Esmailzadeh, F. Pashazadeh, H. Alipour,M. Gjojazadeh, “Anti-Toxoplasma gondii IgG seroprevalence in the general population of Iran: A systematic review and meta-analysis,” Infectious Diseases of Poverty, Vol. 12(1), 99, 2023.
[6] FAO & WHO, “Multicriteria-based ranking for risk management of foodborne parasites,” FAO/WHO Joint Report, 2023.
[7] T. Khan, “Serological detection and molecular confirmation of Toxoplsma gondii in humans,” Diagnostics, Vol. 24(2), 291, 2024.
[8] N.E. Elammari, S.R. Sariti, H.H.M. Boba, M. Y. Al Abbar, “Seroprevalence of IgG and IgM of Toxoplasma gondii among pregnant women at El-Bieda City Libya,” International Journal of Medical Sciencs in Clinical Research and Review, Vol. 4(5), 7-13, 2021.
[9] A.M. Ekhnefer, A.S. Hamd, A.B. Hador, S.M. Bowashia, “The prevalence and morphology of toxoplasmosis in domestic and semi- domestic in Al-bayda City, Libya,” Libyan Journal of Basic Sciences, Special Issue for the 6th International Conferece for Basic Sciences and Their Applications (6th ICBSTA, 2023), Omar Al-Mukhtar University, Oct. 28-29 ,2023.
[10] F.F. Mohammed, M.S. Alasbali, “Toxoplasmosis: Prvalence of Toxoplasma gondii parasite in domestic cats in AL-Marj, Libya,” University of Benghazi of Sciences and Human Studies- Al-Marj, Vol. 17(7), Jun. 3, 2023. National Library Deposit No. 282/2.
[11] S. R.H. Shaha, Z.A. Laghari, A. Malik, M.A. Abdel-Maksoud, M. Aufy, M. Mares, “Exploring the presence and genetic makeup of Toxoplasma gondii in household cats: A fascinating investigation,” Applied Ecology and Environmental Research, Vol. 23(1), 235-253, 2025. DOI: https://doi.org/10.15666/aeer/2301_235253
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Amal S. Hamd, Juma Ahmed Mohamed Ali (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Retention of Rights: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
2. User Rights: This license allows others to remix, tweak, and build upon the work non-commercially, and although their new works must also acknowledge the original author and be non-commercial, they do not have to license their derivative works on the same terms.
3. Restrictions: The material cannot be used for commercial purposes without prior written permission from the author or the journal.
4. Additional Agreements: Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository), with an acknowledgement of its initial publication in this journal.